Cambrian Biopharma

About:

Cambrian is a distributed development company building therapeutics to lengthen health span.

Website: https://www.cambrianbio.com

Twitter/X: cambrianbio

Top Investors: Alumni Ventures, Catalio Capital Management, FJ Labs, SALT Fund, Future Ventures

Description:

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Total Funding Amount:

$160M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2019-01-01

Contact Email:

press(AT)cambrianbio.com

Founders:

Christian Angermayer, James Peyer, Sebastian Brunemeier

Number of Employees:

11-50

Last Funding Date:

2023-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai